United States (USA) Ventilator Market Overview, 2031

The United States has been at the forefront of ventilator innovation and development. Various American companies and research institutions have contributed to advancing the technology, making ventilators more efficient and adaptable to different medical situations. The COVID-19 pandemic highlighted the importance of ventilators in treating severe respiratory cases. In 2020, there was a surge in demand for ventilators and the USA played a crucial role in ramping up production to meet the increased need. The response to the ventilator shortage during the COVID-19 pandemic involved collaborations between the U.S. government, private companies, and non-profit organizations. Initiatives such as the Defence Production Act were utilized to mobilize resources and accelerate ventilator production. Ventilators in the USA are designed to be adaptable for use in various healthcare settings, including hospitals, emergency rooms, and even field hospitals. This adaptability has been crucial, especially during times of crisis or natural disasters. Since the spring, almost 200,000 critical care ventilators have been produced in the United States by medical device manufacturers, of which 155,000 are destined for the Strategic National Stockpile, a dramatic increase in the nation's ventilator capacity. Simultaneously, medical professionals have discovered alternative methods of providing oxygen to patients who are having difficulty breathing during COVID 19. Globally as well as in the United States, there were coordinated attempts to boost ventilator manufacturing in response to this spike in demand. In order to increase production, the U.S. government and commercial businesses called for emergency measures and worked with ventilator manufacturers. In order to fulfil the pressing need for ventilators, there were also measures to reuse already-existing production facilities, seek the assistance of other sectors, and enable collaborations.

According to the research report, " US Ventilator Market Overview, 2031," published by Bonafide Research, the US Ventilator market is anticipated to grow at more than 6.10% CAGR from 2026 to 2031. A poor diet, obesity, and a lack of physical exercise are among the main risk factors that increase the prevalence of respiratory illnesses. The occurrence or severity of diseases including asthma, COPD, exertional dyspnea, pulmonary embolism, aspiration pneumonia, and obesity-hypoventilation syndrome has been linked to weight gain. According to a Better Policies for a Healthier America report, the obesity prevalence among adult Americans is still rising, accounting for four out of ten cases. Because obesity is linked to a number of illnesses, including type 2 diabetes, heart disease, stroke, arthritis, sleep apnea, and some malignancies, it is imperative that the condition be addressed. Obesity is predicted to raise US healthcare spending by more than USD 160 billion a year, including billions from Medicare and Medicaid, according to the Medical Expenditure Panel Survey MEPS. If extra expenses from overweight more than $500 per person are taken into account, this number increases to approximately $195 billion, underscoring the significant economic burden of overweight and obesity in the US. Advances in ventilator technology, including improved functionality, better user interfaces, and enhanced portability, can drive demand as healthcare providers seek to upgrade their equipment. Technological innovation can also lead to the development of more specialised and efficient ventilators. Ventilators are essential in critical care units for patients undergoing surgeries, trauma victims, and those with severe respiratory distress. As healthcare facilities expand and critical care capacities increase, there is a corresponding need for ventilators to support these critical care services.
US ventilator market by product type is divided into intensive care ventilators, portable/transport ventilators and others. In the U.S., the market for ventilators is divided based on product type into intensive care ventilators, portable/transport ventilators, and other categories, each serving unique clinical and care-related needs. Intensive care ventilators hold the largest market share due to their essential function in hospital intensive care units for treating patients with severe breathing issues, complicated comorbidities, or those in need of prolonged mechanical support. These devices are sophisticated, providing accurate control over ventilation modes, real-time patient monitoring, integrated alarms, and compatibility with hospital information systems. Demand in the U.S. remains high because of the widespread occurrence of chronic respiratory conditions like COPD and asthma, an older population, and ongoing investments by hospitals to enhance ICU facilities. Portable and transport ventilators are a rapidly expanding segment, benefiting from their growing application in emergency medical services, patient transfers between hospitals, military use, and at-home care. These ventilators are appreciated for their compact size, battery operation, durability, and capability to provide dependable ventilation during patient movement or in unconventional care settings. Technological advancements have greatly improved the functionality of portable devices, making them comparable to ICU ventilators. The others category comprises neonatal ventilators, high-frequency ventilators, and specialized devices designed for specific clinical situations. Growth in this segment is bolstered by advances in neonatal healthcare, an increase in preterm births in the U.S., and the necessity for customized ventilation methods. Innovations, readiness for public health threats, and a shift towards adaptable care delivery models continue to influence the demand for different product types in the U.S. ventilators market.

US ventilator market by interface is divided into invasive ventilation and non-invasive ventilation. In terms of interface, the U.S. ventilators market is categorized into invasive ventilation and non-invasive ventilation NIV, both fulfilling crucial but different roles in patient treatment. Invasive ventilation, utilizing endotracheal or tracheostomy tubes, generates a considerable share of market revenue due to its common use in intensive care units, emergency rooms, and surgical environments. It is the preferred method of care for critically ill patients who cannot breathe on their own, including those with acute respiratory distress syndrome, severe injuries, or undergoing significant surgeries. In the U.S., the need for invasive ventilation is driven by advanced critical care capabilities, a high volume of surgeries performed, and robust reimbursement frameworks for hospital care. Conversely, non-invasive ventilation is growing at a faster pace, fueled by a clinical inclination towards less invasive methods when appropriate. NIV, administered via masks or similar devices, is frequently utilized for conditions like sleep apnea, COPD flare-ups, and early respiratory failure. Its advantages include a lower risk of ventilator-associated infections, reduced hospital stay durations, and enhanced patient comfort. In the U.S., the increasing focus on value-driven healthcare and cost efficiency has further promoted the use of NIV in hospitals, outpatient facilities, and home settings. Technological progress, including enhanced mask designs and advanced ventilation algorithms, is improving patient adherence and clinical outcomes, strengthening the position of NIV in contemporary respiratory care.

US ventilator market by end user is divided into hospitals and clinics, ambulatory surgical centers, home care settings and others. According to end users, the U.S. market for ventilators is divided into hospitals and clinics, ambulatory surgical centers ASCs, home care environments, and other categories. Hospitals and clinics are the leading part of the market since they serve as the main places for critical care, emergency assistance, and intricate surgical operations that need mechanical ventilation. Major hospitals in the U.S. are making significant investments in sophisticated ventilator technologies to enhance their ICUs, neonatal departments, and readiness for emergencies, particularly after gaining insights from recent health crises. Ambulatory surgical centers, while smaller in size, are experiencing consistent growth, encouraged by the healthcare system's shift towards outpatient and same-day surgical treatments. ASCs need dependable and user-friendly ventilators for anesthesia as well as for recovery after surgery, which is increasing the demand for small and affordable systems. Home care environments are becoming a rapidly expanding segment, driven by the rise in chronic respiratory illnesses, an elderly population, and a strong inclination towards receiving care at home. In the U.S., favorable reimbursement conditions for home respiratory care and improvements in portable ventilator designs have made it easier to manage long-term ventilation at home. The others category includes long-term care homes, rehab centers, and military or emergency response agencies. Growth in this area is supported by the demand for prolonged respiratory assistance beyond conventional hospitals. Changing care models, patient-focused treatment strategies, and goals for cost efficiency are transforming the need for ventilators across various U.S. end-user categories.

"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031
Aspects covered in this report
• Insulin Delivery Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation



By Product Type
• Intensive Care Ventilators
• Portable/Transport Ventilators
• Others

By Interface
• Invasive Ventilation
• Non-Invasive Ventilation (NIV)

By End User
• Hospitals & Clinics
• Ambulatory Surgical Centers (ASCs)
• Home Care Settings
• Others “